4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-20-056229
Director acquired 10,288 shares (option exercise)
- Director gave 10,288 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TARNOW MICHAEL M Director | 2020-10-28 | Option exercise | +5,144 | $3.76 | $19,341 | 74,857 | D: show line 1 in the form |
| TARNOW MICHAEL M Director | 2020-10-28 | Option exercise | +5,144 | $3.76 | $19,341 | 80,001 | D: show line 2 in the form |
| TARNOW MICHAEL M Director | 2020-10-28 | Gift | −10,288 | 69,713 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| TARNOW MICHAEL M Director | 2020-10-28 | Option exercise · Stock Option (Right to Buy) | −5,144 | 0 | D: show line 4 in the form | |||||
| TARNOW MICHAEL M Director | 2020-10-28 | Option exercise · Stock Option (Right to Buy) | −5,144 | 0 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…